Research News
A Cedars-Sinai-led clinical trial found that a once-daily oral medication significantly outperformed placebo in treating adults with moderate to severe ulcerative colitis. The results were published in The New England Journal …
Weight loss drugs known as GLP-1s may help protect against heart failure even at doses too low to produce significant weight loss, according to a laboratory study led by Cedars-Sinai Health Sciences University …
An experimental nanoparticle developed by Cedars-Sinai Health Sciences University investigators, which delivers cancer treatment directly to tumors in the brain, has been selected for evaluation by the Nanotechnology Characterization …
Lung cancer patients undergoing radiation treatment may be at higher risk for developing pulmonary hypertension, a type of high blood pressure that affects the arteries …
Consistent physical activity—especially walking—can reduce fatigue and improve quality of life for colorectal cancer survivors, according to a study led by Cedars-Sinai Health Sciences University investigators. Historically, nearly 40% of …
A team of investigators co-led by Cedars-Sinai Health Sciences University has identified an enzyme that helps prevent the most common form of liver disease from progressing toward liver failure. Results of the …
A team led by Cedars-Sinai Health Sciences University investigators has identified a protein that may hide aging cells from the body’s immune system, allowing them to build up and contribute to age-related health …
Investigators at Cedars-Sinai Health Sciences University used an experimental drug to reverse the effects of systemic sclerosis, a serious autoimmune disease. The study, conducted in a laboratory, was published in …
A new study led by Cedars-Sinai Health Sciences University investigators found that prostate-specific antigen (PSA) levels in the blood, which are used …